Leading the Way in Life Science Technologies

GEN Exclusives

More »

Best of the Web

More »
Aug 01, 2005 (Vol. 25, No. 14)

National Nuclear Data Center

URL:www.nndc.bnl.gov/index.jsp
  • Communications options
  • Too little information
The extent of my knowledge of atomic nuclei and nuclear chemistry is pretty much bounded by the knowledge of isotopes, half-lives, and decay particles I obtained in freshman chemistry. It is therefore with trepidation that I wade into the vast waters of the National Nuclear Data Center. Organized at the Brookhaven National Laboratory as an extensive set of links to all things nuclear, the site points visitors to nuclear structure/decay databases, nuclear reaction databases/tools, bibliography collections, data sheets, cleverly designed Nuclear Wallet Cards organized by element, and an extensive array of references, and data (some unevaluated). How’s that for thinking or swimming?
  • Key:
  • Strong Points
  • Weak Points
  • Ratings:
  • Excellent
  • Very Good
  • Good


*The opinions expressed are solely those of the author(s) and should not be construed as reflecting the viewpoints of the publisher, Genetic Engineering & Biotechnology News, Mary Ann Liebert, Inc., the publishing house, or employees and affiliates thereof.

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »